{"filing":{"accession_number":"0001739104-26-000040","cik":"0001739104","ticker":"ELAN","company_name":"Elanco Animal Health Inc","form":"8-K","filing_date":"2026-08-05","report_date":"2026-08-05","primary_document":"elan-20260805.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1739104/000173910426000040/elan-20260805.htm"},"events":[{"id":25231,"run_id":22895,"accession_number":"0001739104-26-000040","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a clear earnings release disclosing Elanco's second quarter 2026 financial results, including revenue of $1,368 million (10% YoY growth), adjusted net income of $174 million, and adjusted EPS of $0.34. The filing also provides updated full-year 2026 guidance with raised revenue, EBITDA, and EPS targets. The press release is dated August 5, 2026, and is attached as Exhibit 99.1 to Item 2.02, which is the standard Item for results of operations disclosures.","company_name":"Elanco Animal Health Inc","ticker":"ELAN","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":[{"id":26001,"accession_number":"0001739104-26-000040","item_number":"2.02","item_title":"Results of Operations or Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Elanco's second quarter 2026 financial results, including revenue of $1,368 million (10% YoY growth), adjusted net income of $174 million, and adjusted EPS of $0.34. The filing also provides updated full-year 2026 guidance with raised revenue, EBITDA, and EPS targets. The press release is dated August 5, 2026, and is attached as Exhibit 99.1 to Item 2.02, which is the standard Item for results of operations disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:21:11.198548+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26001,"accession_number":"0001739104-26-000040","item_number":"2.02","item_title":"Results of Operations or Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Elanco's second quarter 2026 financial results, including revenue of $1,368 million (10% YoY growth), adjusted net income of $174 million, and adjusted EPS of $0.34. The filing also provides updated full-year 2026 guidance with raised revenue, EBITDA, and EPS targets. The press release is dated August 5, 2026, and is attached as Exhibit 99.1 to Item 2.02, which is the standard Item for results of operations disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:21:11.198548+00:00","company_name":"Elanco Animal Health Inc","ticker":"ELAN","filing_date":"2026-08-05"}]}